$AZO

AutoZone In, SpaceX Out: HALX’s New Rebalance

The Tuttle Capital Heavy Assets Low Obsolescence Index (HALX) was rebalanced, adding AutoZone, United Therapeutics, and others, while removing SpaceX and four other companies. The index focuses on firms with heavy assets and low AI disruption risk, potentially benefiting investors concerned about AI's impact.

Original reporting
Published Sep 21, 2026, 8:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 9:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$AZO
Bullish
medium confidence
Mentioned
$AZO · $UTHR · $MTD · $NI · $CPRT · $AEP
Relevance
6/10
AlphAI data visualization · based on etfdb.com
Decision brief

The 30-second read

$AZOBullishMed
01

Why it matters

Inclusion or exclusion can cause short‑term price moves as index funds trade, but long‑term impact depends on underlying fundamentals.

02

Market read

The rebalance creates trading opportunities for the eight listed U.S. stocks as passive fund flows adjust.

03

What to watch

Potential liquidity constraints of HALX may limit the magnitude of price moves from the rebalance.

Relevance 6/10Novelty 6/10Timing: post‑rebalance today

Background

ETF index rebalances periodically adjust holdings to maintain strategy criteria; HALX targets heavy‑asset, low‑obsolescence companies.

Company-level read

Ticker impact

$AZOBullishMedium confidence
Context

AutoZone was added to the Tuttle Capital Heavy Assets Low Obsolescence ETF (HALX) in the latest index rebalance.

Expected impact

Small upward pressure on AZO price.

Evidence & confidence

Inclusion in a low‑obsolescence ETF may attract passive capital.

$UTHRBullishMedium confidence
Context

United Therapeutics was added to HALX in the recent rebalance.

Expected impact

Slight price increase expected.

Evidence & confidence

ETF addition creates new demand for shares.

$MTDBullishMedium confidence
Context

Mettler‑Toledo was added to HALX in the latest index rebalance.

Expected impact

Minor upside potential.

Evidence & confidence

Passive fund purchases can lift price modestly.

$NIBullishMedium confidence
Context

NiSource was added to HALX in the recent rebalance.

Expected impact

Small upward move likely.

Evidence & confidence

Utility inclusion in a low‑obsolescence ETF attracts passive inflows.

$CPRTBullishMedium confidence
Context

Copart was added to HALX in the latest index rebalance.

Expected impact

Slight price rise expected.

Evidence & confidence

New exposure for index‑tracking funds.

$AEPBearishMedium confidence
Context

American Electric Power was removed from HALX in the latest index rebalance.

Expected impact

Potential short‑term downside.

Evidence & confidence

ETF may divest, creating temporary sell pressure.

$WYBearishMedium confidence
Context

Weyerhaeuser was removed from HALX in the recent rebalance.

Expected impact

Small downside risk.

Evidence & confidence

Index removal can lead to short‑term price dip.

$JBHTBearishMedium confidence
Context

J.B. Hunt was removed from HALX in the latest index rebalance.

Expected impact

Minor decline possible.

Evidence & confidence

ETF removal often triggers modest sell‑off.

Market effects

The rebalance highlights a tilt toward low‑AI‑disruption assets, favoring industrial, utility and healthcare names.

U.S. equity markets may see modest flows into the added stocks, while removed names could face short‑term pressure.

Limited to U.S. investors tracking HALX; broader market impact is minimal.

Counterpoint

The index's low‑obsolescence focus may overlook growth opportunities, so added stocks could underperform broader market.

Key entities

  • Tuttle Capital

    Provider of the HALX ETF and its underlying index.

  • HALX

    Tuttle Capital Heavy Assets Low Obsolescence ETF.

Related articles

$AZOLow

Fitch Affirms AutoZone at 'BBB'; Outlook Stable

Fitch Ratings affirmed AutoZone Inc.'s long-term and short-term debt ratings at 'BBB' and 'F2' respectively, with a stable outlook. The ratings reflect AutoZone's strong market position, consistent growth, and stable credit metrics. Fitch expects EBITDAR leverage to remain low, despite potential debt increases for share buybacks. AutoZone's strategic initiatives, including store expansion and international growth, are seen as positive for long-term market share gains.

$NIMed

NI Stock Edges Higher After-Hours On Deals With Alphabet, Amazon

Nisource Inc. (NI) shares rose 3% after-hours following long-term energy deals with Alphabet (GOOG, GOOGL) and Amazon (AMZN) for data center projects. The Alphabet deal supports a large-scale data center in Indiana, starting in 2026, while the Amazon deal accelerates site energization, aiming for $1.25B in customer savings. NI stock has gained 13% YTD, GOOG 5%, and AMZN 10%.

$UTHRHigh

Why United Therapeutics (UTHR) Shares Are Falling Today

United Therapeutics (UTHR) shares fell 4% after Goldman Sachs initiated coverage with a Sell rating, signaling expected underperformance. The stock later recovered slightly to $470.94, down 3.8%. UTHR is down 5.2% YTD and 21.1% from its 52-week high. The company's drug, Tyvaso, showed positive results in a study for lung disease treatment.

$UTHRHigh

United Therapeutics Falls as Goldman Sachs Sets $321 Price Target

United Therapeutics' shares dropped after Goldman Sachs gave it a Sell rating and a $321 price target, citing high growth expectations and valuation concerns. The firm sees challenges in commercializing Tyvaso and new therapies. Goldman also downgraded Sagimet Biosciences to Sell with a $7 target, citing commercial hurdles.

$AZOHighAI 9/10

AutoZone Reports $20.3 Billion In Annual Revenue And $56.05 In Fourth-Quarter Earnings Per Share

AutoZone reported fiscal 2026 revenue of $20.3B (+7.4% Y/Y) and Q4 EPS of $56.05. Q4 revenue rose 5.6% to $6.6B, with net income up 11.3% to $931.6M. Gross margin improved 182 bps to 53.3%, aided by tariff refunds. The company opened 175 stores, expanding its global footprint to 8,031 locations. Annual EPS increased 5.3% to $152.55, with $2B spent on share repurchases.